Privacy Policy

We have created this statement to demonstrate our firm commitment to privacy. The following discloses the information gathering and dissemination practices for this website.

We use your IP address to help diagnose problems with our server, and to administer our website. Your IP address is used to gather broad demographic information.

This site contains links to other sites. We are not responsible for the privacy practices or the content of such website.

Our online surveys ask visitors for contact information (like an email address) and demographic information (like zip code, age, or income level). We use contact data from our surveys to send the user information about our company and announcements or alerts from some of our partners. The customer's contact information is also used to contact the visitor when necessary. Users may opt-out of receiving future mailings; see the choice/opt-out section below. Demographic and profile data is also collected at our site. We use this data to tailor our visitor's experience at our site, showing content that might be of interest, and displaying content according to preferences. Users may opt-out of receiving future mailings; see the choice/opt-out section below.

Security

This site has security measures in place to protect the loss, misuse and alteration of the information under our control.

Choice/Opt-Out

Our site provides users the opportunity to opt-out of receiving communications from us and our partners at the point where we request information about the visitor.

This site gives users the following options for removing their information from our database so they will not receive future communications or receive our service.

To Opt-Out from our emailing list click here: Opt-Out now.

Correct/Update

This site gives users the following options for changing and modifying information previously provided 

Contact Us

Contacting the website

If you have any questions about this privacy statement, the practices of this site, or your dealings with this website, please visit our contact page.

Vaccine Vision

A broad family of room temperature stable vaccines self administered via a painless patch...

read more
Featured Article
Featured Team Member

Dr. D. R. Henderson
Chief Executive Officer

Dan has experience and success in founding and building biopharmaceutical companies. He holds a Ph.D. in Medical Sciences from the University of New Mexico School of Medicine and was a postdoctoral scholar at Duke University Medical Center. He founded Microgenics Corporation. At Microgenics, Dan invented the CEDIA™ immunoassay system used in clinical laboratories throughout the world. CEDIA™ immunoassays now sell over $1B annually: please see www.usdiagnostics.roche.com and then search for CEDIA™ on their website; repeat at www.thermofisher.com. For this work, the American Association for Clinical Chemistry (AACC) awarded the 2015 biennial Ullman Prize for Technology Innovation to Dr. Henderson.

Dan also founded Calydon where he genetically engineered adenovirus targeting prostate cancer. For this work he was recognized as one of the two pioneers in the field of oncolytic virotherapy (Scientific American, “Tumor Busting Viruses”, October 2003). Calydon was sold to Cell Genesys. 2015 saw the first FDA approved oncolytic virus, a herpesvirus for melanoma.

Dr. Henderson also co-founded PaxVax, a manufacturer and developer of vaccines for travelers to countries without adequate water sanitation (Typhoid, Cholera and Hepatitis A) and the U.S. Military (Anthrax) (see www.paxvax.com). PaxVax was named Best Early-Stage Vaccine Biotech company at the 16th annual World Vaccine Congress in Washington, D.C., March, 2016 and received FDA approval for a Single Dose Oral Cholera vaccine in June. Dan holds 34 issued US Patents.

read more